By April Dembosky, published in Kaiser Health News
Hospitals across the country are struggling to deal with a shortage of one of their essential medical supplies. Manufacturers are rationing saline - a product used all over the hospital to clean wounds, mix medications and treat dehydration.
The New York University (NYU) Langone Medical Center is now using a novel technology that serves as a "flight simulator" for neurosurgeons, allowing them to rehearse complicated brain surgeries before making an actual incision on a patient.
The new simulator, called the Surgical Rehearsal Platform (SRP), creates an individualized walk-through for neurosurgeons based on 3D imaging taken from the patient’s CT and MRI scans.
Research conducted at the Texas Biomedical Research Institute, published in the latest issue of the scientific journal Pigment Cell and Melanoma, has established unequivocally in a natural animal model that the incidence of malignant melanoma in adulthood can be dramatically reduced by the consistent use of sunscreen in infancy and childhood.
The Centers for Medicare & Medicaid Services (CMS) launched a national initiative “From Coverage to Care” (C2C), which is designed to help answer questions that people may have about their new health coverage, to help them make the most of their new benefits, including taking full advantage of primary care and preventive services. It also seeks to give healthcare providers the tools they need to promote patient engagement.
Written by Marissa Evans, published in Kaiser Health News:
“Person-centered care” is the buzz phrase floating around the healthcare industry, and a Pacific Northwest-based giant insurer thinks it has hit the mark with a new palliative care program coming this summer.
University of Texas Southwestern Medical Center researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression.